The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.
One month after beginning coverage on a number of molecular diagnostics firms, the investment bank initiated coverage on Illumina, Life Technologies, Waters, Thermo Fisher Scientific, and Sigma-Aldrich.
Agilent Technologies' recent announcement that it had shifted to Singapore production of several high-end LC/MS systems was just the latest in a series of decisions by large instrument vendors to move manufacturing to the island nation.
The company's Life Sciences Group reported $431 million in revenues, with all platforms posting double-digit sales increases including a 21-percent rise in liquid chromatography sales led by the strong performance of the 1290 and 1260 Infinity LC lines.
In a third quarter earnings call, CEO Douglas Berthiaume said growing demand for the Acuity H-Class UPLC platform helped drive a 9-percent rise in instrument sales year over year, while total receipts increased 9 percent and profit widened 25 percent.